drugset / Trial / NCT02903238

Brain Morphometry in OA Patients Treated With Duloxetine

NCT02903238

NaSingle-groupSingle-blindBasic science

Summary

This is a two week,single-blind study evaluating pain response and changes in brain imaging upon treatment with placebo in people with knee OA.

Timeline

Start
2011-07
Primary completion
2011-10
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Background Duloxetine Small molecule 60 mg

Indications